title: Severe interstitial pneumonitis secondary to pegylated interferon alpha-2b and ribavirin treatment of hepatitis C infection.
authors.affiliation: Department of Internal Medicine 4, General Hospital and University of Vienna, Vienna, Austria.
authors.forename: Valentin
authors.initials: V
authors.lastname: Fuhrmann
authors.forename: Ludwig
authors.initials: L
authors.lastname: Kramer
authors.forename: Edith
authors.initials: E
authors.lastname: Bauer
authors.forename: Hermann
authors.initials: H
authors.lastname: Laferl
authors.forename: Gerhard
authors.initials: G
authors.lastname: Tucek
authors.forename: Gerhard
authors.initials: G
authors.lastname: Dekan
authors.forename: Peter
authors.initials: P
authors.lastname: Schenk
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D017809:Fatal Outcome; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C417083:peginterferon alfa-2b